Patients with Systemic Sclerosis/polymyositis Overlap Have a Worse Survival Rate Than Patients Without It.
Bhansing, Kavish J; van Riel, Piet L C M; van Engelen, Baziel G M; Fransen, Jaap; Vonk, Madelon C.
; 43(10): 1838-1843, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27528573
Smoldering multiple myeloma requiring treatment: time for a new definition?
Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factors.
Are respiratory complications common causes of death in inflammatory myopathies? An autopsy study.
Prichiny smerti bol'nykh s revmaticheskimi zabolevaniiami v Moskve.
Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
Air hunger, unwelcome guests, clogged pipes and idiopathic inflammatory myositis: can we do better?
Clinical Heterogeneity of Interstitial Lung Disease in Polymyositis and Dermatomyositis Patients With or Without Specific Autoantibodies.
Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis.
Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.
Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study.